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ABSTRACT 
The Ability of Central Leptin Administration to Induce Phosphorylation of STAT3 in 
Lactating Rats 
Radek Eric Budin 
Leptin secreted from white fat acts in the brain to decrease food intake and increase 
energy expenditure. Although the discovery of leptin promised a powerful way of 
combating obesity, subsequent research suggested that most obese individuals were 
actually resistant to the effects of leptin. High circulating levels of leptin are most 
commonly associated with leptin resistance but evidence is accumulating that sensitivity 
to leptin differs between sexes and across reproductive states. For example, earlier studies 
suggest that peripheral administration of leptin is less effective in decreasing food intake 
in lactating than in cycling rats. Leptin's effects on food intake are believed to be 
mediated primarily through activation of the JAK/STAT and the resulting 
phosphorylation of STAT3. In the present study the ability of central leptin injections to 
induce PSTAT3-ir in the VMH, PVN, and ARC was compared among cycling rats (Cyc) 
and lactating females on either postpartum day 4 or 16. Results show that in all 
hypothalamic areas examined there were more PSTAT3 positive cells in rats receiving 
leptin than those receiving saline. Within the PVN, this response was attenuated in the 
lactating groups and was most reduced on Day 16 postpartum. These results further 
support previous findings that there is a reduction in leptin sensitivity that occurs during 
the lactational period. 
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INTRODUCTION 
Leptin, an adipose-derived hormone, that acts in the brain to increase energy 
expenditure and reduce appetite, was discovered in 1995 (Halaas et al., 1995). This 
breakthrough was thought to be monumental because it was believed that leptin could be 
used as a treatment for obesity. However, such hopes were quickly met with 
disappointment, since it is now understood that most cases of obesity are related to high 
circulating leptin levels and an inability to respond to the effect of this protein (Friedman 
& Halaas, 1998). Obesity research has now focused on uncovering the mechanisms 
underlying leptin resistance. Accumulating evidence suggests that, in many cases, high 
circulating levels of leptin lead to central resistance, however, in some situations 
sensitivity to this hormone changes as an adaptive response to particular physiological 
requirements such as the increase in fat storage that occurs prior to hibernation and 
during pregnancy (Kronfeld-Schor, Richardson, Silvia, Kunz, & Widmaier, 2000; 
Ladyman, 2008). In this thesis the possibility that leptin sensitivity is also changed 
during lactation, a reproductive state associated with a dramatic increase in food intake, 
was investigated. Because the ability of leptin to induce the phosphorylation of signal 
transducer and activator of transcription (PSTAT) is a key step through which leptin 
suppresses food intake, the ability of central leptin to induce PSTAT3 was compared 
among cycling and lactating rats. 
The notion that fat stores play a role in the homeostatic mechanisms controlling 
food intake and energy balance is not a novel proposal. In 1953, Gordon Kennedy put 
forward his "lipostasis" hypothesis which suggested that "metabolites" generated by the 
periphery at levels proportional to fat stores are released into the circulation and 
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determine the amount of food that an organism consumes and the degree of energy it 
expends, thus resulting in a relatively consistent body weight (Kennedy, 1953; Langhans 
& Geary, 2005, chap. 2). Evidence for such a compound(s) first emerged from a 
parabiosis experiment carried out by Hervey (1959) that involved the surgical union of 
two rats resulting in a shared circulatory system. Such a manipulation allowed humoral 
factors to freely flow from one animal to the next. Following the joining of the pair, one 
of the parabionts received an electrolytic lesion to the area of the hypothalamus. This 
manipulation resulted in increased food intake and obesity in lesioned animals while the 
conjoined partner reduced its food consumption and lost weight. If the joined partner with 
the intact hypothalamus was subsequently lesioned, it too began to overeat and gain 
weight. This experiment was the first to demonstrate that Kennedy's proposed blood 
borne factor worked by reducing food intake and weight and that it required an intact 
hypothalamus to do so (Hervey, 1959; King, 2006). 
Investigations involving murine genetic syndromes of obesity provided further 
insight into candidates for such satiety factors(s). One of these syndromes was 
discovered at Roscoe B. Jackson Memorial Laboratories in 1949 when it was observed 
that in comparison to their wild type counterparts, certain mice were hyperphagic and as 
a result were heavier by four-fold, diabetic (type II), and infertile. Furthermore, these 
animals exhibited hypogonadism, hypothermia, as well as increases in circulating 
corticosterone (Ingalls, Dickie, & Snell, 1949: Elias, Kelly, Lee, Ahima, Drucker, Saper, 
& Elmquist, 2000). It was eventually determined that these mutants were homozygous 
for a recessive gene that would come to be known as the obese (ob) gene. Another model, 
discovered in the same lab in 1966, known as the diabetes mouse, is recessive for the db 
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gene, and resembles the ob/ob mouse with the exception that its symptom onset is earlier 
and it has a shorter life expectancy (Hummel, Dickie, & Coleman, 1966). 
Using the parabiosis procedure, Coleman and Hummel (1969) connected the 
circulation of the db/db mouse to a wildtype mouse, and demonstrated that the non-
mutant partner had a reduction in blood glucose and lost weight at an accelerated rate, 
with most subjects succumbing to these effects within 7 weeks of being attached. This 
suggested that a satiety compound circulating in the db/db mouse had potent effects on 
the wildtype mouse while being unable to exert similar effects on the db/db mouse, 
exhibiting a type of resistance (Coleman & Hummel, 1969). When the ob/ob mouse was 
subjected to this same procedure, however, the effect was very different. The mutant 
parabiont did not exhibit its typical phenotype, but instead increased weight at a reduced 
pace and did not become obese. These results pointed to the existence of an appetite 
reducing compound in the wildtype mouse that was able to exert an effect on the ob/ob 
mouse (Coleman 1973). 
Armed with the evidence from the research described above, the lipostatic signal 
that Kennedy had proposed over 40 years earlier was awaiting its discovery. In 1994, 
Friedman and his colleagues went on to clone and sequence the gene of the ob mouse and 
the homologue in hominoids (Zhang et al., 1994). From their work, they were able to 
determine that the ob gene codes for a protein that acts as a circulating factor to produce 
satiety. In the following year, the team was able to express the ob gene in bacteria and 
purify its product. They named the resulting protein leptin, originating from Greek word 
leptos, meaning thin (Halaas et al., 1995). 
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Using a recombinant form of the OB protein, Halaas et al. (1995) administered 
the product to C57BL/6J ob/ob mice, and C57BL/Ks db/db mice intraperitoneally. The 
researchers discovered that after daily injections for 33 consecutive days, ob/ob mice 
were able to lose approximately 40% of their original weight when compared to vehicle 
controls. This reduction was driven primarily by a reduction in hyperphagia. 
Furthermore, there was a marked improvement in the diabetes condition typically 
seen in this murine model. In sharp contrast, db/db mice failed to respond to the OB 
protein with a reduction in food intake or body weight when compared to subjects 
receiving a vehicle injection. On the other hand, wild-type mice receiving exogenous 
leptin responded with a decrease in body weight. From these results the authors 
concluded that ob/ob mice suffer from a lack of leptin production, while the db/db mice 
are resistant to the biological effects of the OB protein (Halaas et al., 1995). Similar 
results were found by Pelleymounter and colleagues (1995) and by Campfield and 
colleagues (1995), both suggesting that the OB protein is involved in the regulation of fat 
deposition and body weight by affecting appetite and energy balance (For review see 
Castracane & Henson, 2006, chap. 1). 
Since its initial discovery, much information has been gleaned regarding the 
nature and function of leptin. Leptin is a protein consisting of 167 amino acid residues 
that are synthesized principally by the white adipose tissue (WAT) and to a lesser extent 
by the brown adipose tissue (BAT), the placenta and stomach (Zhang et al., 1994; 
Masuzaki et al., 1997; Bado et al., 1998). This hormone is released in the periphery and 
circulates in the blood stream at levels that are primarily determined by the amount of 
stored triglycerides (Maffei et al., 1995). Leptin binds to specific receptors (ObR). which 
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fall into the family of class I cytokines. ObR are themselves a product of the db gene, 
which was found to be dysfunctional in the obese db/db mouse (Tartaglia et al., 1995). 
The db gene has been localized to chromosome Ip in humans and 4 in mice (Chung, 
Kehoe, Chua, & Leibel, 1996). To date, six isoforms of the Ieptin receptor have been 
discovered, ObRa-ObRf. ObRa and ObRc, localized to the choroid plexus and epithelial 
cells, are candidates for mediating the active transport mechanism that is involved in 
allowing Ieptin to reach the brain from the circulation (Cioffi, 1996; Bouret, 2008; 
Kastin, Pan, Maness, Koletsky & Ernsberger, 1999). 
ObRe acts as a soluble binding protein as opposed to a receptor and has not been 
found in humans (Li et al., 1998). The ObRf subtype is unique to the rat, while ObRd 
receptor subtype exists only in mice (Wang, Zhou, Newgard, & Unger, 1996). Only two 
of these receptor subtypes have been shown to have intracellular signaling capabilities: 
the long ObRb and short ObRa Ieptin receptor isoforms (Uotani, Bjorbaek, Tornoe, & 
Flier, 1999). The ObRb is unique in its ability to fully engage signaling of the Janus 
kinase/signal transducer and activator of transcription (JAK/STAT) pathway and it is 
richly expressed in the hypothalamus (For review see Schulz & Widmaier, 2006, chap. 
2). 
JAK/STAT pathway activation is a critical step in the control of food intake and 
ObRb is coupled to this pathway by Ieptin. When Ieptin attaches itself to ObRb, it results 
in the addition of a phosphate to the JAK proteins that are associated with the receptor. In 
turn, this leads to the phosphorylation of several tyrosine sites on the receptors which 
include amino acid residues 1138 and 985 (McCowen, Chow, & Smith, 1998). This then 
provides a site to which signal transducer and activator of transcription 3 (STAT3) 
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proteins can bind, causing them to become phosphorylated by JAK2. These 
phosphorylated STAT3 (PSTAT3) proteins then detach and go on to form homodimers in 
the cytoplasm, translocate to the nucleus and control the transcription of genes (Bjorbaek 
& Kahn, 2004; Leonard & O'Shea, 1998). Of the immediate early genes that are 
transcriptionally regulated by PSTAT3, the suppressors of cytokine signaling (SOCS) 
molecules are important in a negative feedback loop that operates intracellularly thereby 
stopping the JAK/STAT pathway from being stimulated excessively (Bjorbaek, El-
Haschimi, Frantz, & Flier, 1999). Phosphotyrosine phosphotase 1 B (PTP1B) is another 
negative regulator of leptin signaling which follows the activation of ObRb (Zhang & 
Scarpace, 2006). Although activation of the JAK/STAT pathway has been most strongly 
linked to leptin's effects on food intake, this hormone also acts through other intracellular 
signaling pathways including the phosphatidylinositol 3 (PI3) kinase and mitogen-
activated protein (MAP) kinase pathways (Berti, Kellerer, Capp, & Haring, 1997; 
Takahashi et al., 1997). 
Leptin receptor messenger ribonucleic acid (mRNA) has been found in a number 
of tissues throughout the body including the placenta (Lea et al., 2000), skeletal muscle 
(Muoio, Dohn, Fiedork, Tapscott, & Coleman, 1997), liver (Reyes, Lazalde, Posadas del 
Rio, & Escalante, 2008), stomach (Bado et al., 1998), pancreas (Kieffer, Heller, & 
Habener, 1996), brown and white adipose tissues (Sarmiento et al., 1997), and the brain 
(Li, Wang, & Yeh, 1999). Despite the abundance of these receptors, it appears as though 
leptin exerts most of its effects on energy balance in the brain, and most researchers have 
focused on its effects in the hypothalamus. 
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Within the hypothalamus, several nuclei have been found to express ObRb 
mRNA including the arcuate nucleus (ARC), lateral hypothalamus (LH), dorsomedial 
nucleus (DMH), ventromedial hypothalamus (VMH), ventral premammary nuclei 
(PMV), and the paraventricular nucleus (PVN) (Mercer et al., 1996; Fei et al., 1997; 
Elmquist et al., 1998). Recent evidence suggests that leptin is one of a multitude of 
neural, hormonal, and metabolic communications originating from the peripheral system 
that are received and integrated by these nuclei (Smith & Grove, 2002). 
The ARC contains two populations of "first order" neurons which are responsive 
to leptin (Coll, Farooqi, & O'Rahilly 2007). One set of neurons colocalize neuropeptide 
Y (NPY) and agouti-related protein (AgRP) which are both orexigenic (Hahn, Breninger, 
Baskin, & Schwartz, 1998). AgRP acts as an antagonist at melanocortin receptors (MCR) 
types 3 and 4, while NPY, which is the most potent orexigenic agent yet discovered, has 
its effects on food intake by acting at the Yl and Y5 receptors. NPY/AGRP neurons 
project from the ARC to other hypothalamic nuclei such as the PVN, DMH, and LH 
where they regulate ingestive behavior (Smith & Grove 2002). Electrophysiological 
studies have shown that leptin treatment increases inhibitory postsynaptic potentials in 
the NPY/AGRP neurons of the ARC (Riediger, Traebert, Schmid, Scheel, Lutz & 
Scharrer, 2003) and it has been reported that this hormone actually increases the number 
of inhibitory synapses on these neurons (Horvath, 2006). In the absence of leptin, NPY 
expression in the ARC is increased, and these neurons are more active (Cohen et al., 
2001). 
By contrast, when leptin binds to its receptor on proopiomelanocortin peptide 
(POMC) neurons, their membrane potential is reduced and firing rates of the axons are 
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increased (Cowley et al., 2003). Both CART (cocaine and amphetamine-regulated 
transcript) (Kristensen et al., 1998) and alpha melanocyte-stimulating hormone (a MSH), 
a cleavage product of POMC, reduce food intake and increase energy expenditure; but 
the latter appears to be more potent (Seeley et al., 1997). The increased activity of 
POMC neurons following leptin administration results in increased release of a MSH 
which acts through MCR-3 and MCR-4 activation to decreased food intake (Hsiung et 
al., 2005). Dense groupings of MCR-3 can be found in the ARC, VMH, and the preoptic 
nucleus, while MCR-4 is found in abundance in the PVN, DMH, and the LH (Shimizu, 
Inoue, & Mori 2007). The activation of POMC/CART neurons by leptin has widespread 
effects since they project both within the hypothalamus (PVN and LH) and beyond to 
areas such as the amygdala, septum, and the brainstem (Chen, Williams, Grove, & Smith 
2004). 
The ARC is not the only site of leptin action in the hypothalamus or the only site 
at which leptin plays a critical role in the control of body weight. Leptin receptors have 
been detected on the steroidogenic factor 1 (SF-1) neurons in the VMH and deletion of 
these cells leads to obesity (Dhillon et al., 2006). Activation of PVN neurons, which 
release corticotrophin releasing hormone (CRH) can be blocked with the administration 
of leptin (Huang, Rivest, & Richard, 1998) and the longform of the leptin receptor has 
also been localized to oxytocin (OT) neurons in the PVN (Kokay, Bull, Davis. Ludwig, & 
Grattan, 2006). ObRb is also present in LH neurons expressing melanin concentrating 
hormones (MCH) (Stepanyan et al., 2003). 
Assays that have examined activation of c-Fos and STAT3 have also identified 
extra-hypothalamic brain areas that are responsive to leptin including the parabrachial 
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nucleus (PBN), periaqueductal gray (PAG), the dorsal raphae (DR) of the midbrain, the 
nucleus of the solitary tract (NTS) in the caudal brainstem and the ventral tegmental area 
(VTA) (Muenzberg, Huo, Nillni, Hollenberg & Bjorbaek, 2003). Evidence has so far 
failed to implicate any of these leptin responsive non-hypothalamic regions in food intake 
or energy balance directly, with the exception of the VTA, in which leptin administration 
has been found to reduce the consumption of food (Hommel et al. 2006). 
In summary, leptin is generally considered to provide a signal of long-term energy 
stores to the neural circuitry sub-serving food intake and energy expenditure. Usually 
when there is a high degree of adipose tissue, there is an increase in leptin which acts at 
the level of the ARC to inhibit the NPY/AgRP neurons and hence reduces feeding, while 
exciting the POMC/CART neurons to release anorexic neuropeptides. In contrast, when 
there is a loss of leptin signaling, there is a decrease in energy expenditure and an 
increase in food intake (van de Wall et al., 2008). 
When leptin was discovered, it was hoped that it might lead to the development of 
a therapeutic agent that could prevent or even reverse obesity (Henry & Clarke, 2008). 
Experiments which exhibited the effectiveness of leptin administration to reverse the 
ob/ob mouse condition and to reduce food intake in normal weight rodents provided 
evidence that this hormone might in fact be an effective anti-obesity agent. However, 
attempts of the pharmaceutical industry to develop leptin as a therapy for obesity were 
met with disappointment when it was found that weight reduction only occurred in a 
small proportion of obese individuals (approximately 5-10% have low leptin production). 
Closer investigation of obese non-responders revealed that unlike the ob/ob model, in 
which the lipostatic signal is not produced, overweight subjects have increased plasma 
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levels of leptin in comparison to controls. This suggests a condition of leptin resistance in 
most forms of obesity whereby the periphery provides accurate signals with regards to 
the proportion of fat stores; however this signal fails to exert a central effect at the level 
of the brain (Friedman & Halaas, 1998). These findings led obesity researchers to change 
their focus to uncovering the mechanisms underlying this leptin resistant state. 
Several hypotheses have been forwarded to explain the causes of leptin resistance. 
One posits that there is a defect in the transport system of leptin from the periphery into 
the brain. For example, F344xBN rats that exhibit an increase in adiposity with age have 
been found to have a decreased response to peripheral versus central infusions (Scarpace, 
Matheny, & Shek, 2000). Another suggested mechanism involves a decrease in the 
number of leptin receptors within the hypothalamus. Decreased ObR mRNA has been 
found to be related to age related obesity (Scarpace, Matheny, Moore, & Turner, 2001). 
Finally disruptions in intracellular signaling have also been suggested as a mechanism 
behind leptin resistance (Sahu, 2003). It has been shown that leptin activation of STAT3 
is reduced in normal mice that become obese through exposure to high fat diets 
(Haschimi, Pierroz, Hileman, & Bjorbaek, 2000). It is also possible that SOCS3 may 
indirectly contribute to leptin resistance. It has been found that in mice with diet induced 
obesity (DIO), within the ARC there is an increase in SOCS3 expression (Henry & 
Clarke, 2008) 
Since human obesity involving leptin receptor gene or leptin gene mutations are 
very rare, research has focused on developing models that more closely approximate the 
most common origin of this condition (Bell & Considine, 2006, chap. 3). The recent rapid 
of obesity suggests that genes alone cannot provide a full explanation (Archer & Mercer 
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2007). Environmental conditions that include a lifestyle of low physical activity 
combined with the consumption of palatable food that is dense in energy increases the 
risk of the development of obesity substantially, and are the cause of the majority of these 
cases. Thus investigators examining the mechanisms of leptin resistance have primarily 
utilized animal models of DIO, considered to be physiological responses that are 
generally maladaptive (Ladyman, 2008). 
Although not directly analogous to the typical diet of Westerners, these models 
provide rodents with access to a highly palatable solid or liquid supply of sugar or fat in 
addition to their standard commercial pellet food diet. Generally it has been reported that 
vulnerable rodents exposed to these obesogenic diets for an extended period of time are 
hyperphagic and have a 10% to 20% gradual increase in overall weight compared to 
controls. These effects are highly dependent on the type of rodent and strain that are 
employed, although employing rats in this type of research is most advantageous since 
their size allows for more endpoints to be examined such as catheter techniques 
(Buettner, Scholmerich, & Bollheimer, 2007). 
Close investigation of DIO models has revealed important clues to the nature of 
this condition. For example, in one experiment obesity was induced in mice by prolonged 
exposure to a high fat diet. Prior to becoming obese these animals were responsive to 
leptin administered peripherally, however after 8 weeks of high fat feeding they no longer 
reduced food intake in response to this treatment. Interestingly, these animals reduced 
food intake in response to central administration (Van Heek et al., 1997). Furthermore, in 
DIO models, phosphorylation of STAT3 does not occur after peripheral administration, 
but does after intracerebral ventricular administration (Vaisse, Halaas, Horvath, Darnell 
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Jr, Stoffel, & Freidman, 1996). These findings provide some support for the idea that 
there may be a problem with transport of leptin from the periphery to the brain. Although 
a defect in leptin transport through the Ob-Ra and Ob-Rc might contribute to these results 
reduction in Ob-Ra and Ob-Rc mRNA in DIO could explain the findings. Data from 
other models of diet induced obesity suggest leptin resistance of central origin. For 
example, DIO Wistar rats that received an infusion of leptin into the lateral ventricles 
exhibited a reduced anorexic effect compared to controls (Levin & Dunn-Meynell, 2002; 
Widdowson, Upton, Buckingham, Arch, & Williams, 1997). Similar findings were 
obtained with DIO Sprague Dawley rats, AKR/J mice, and AY mice (Sahu 2004). 
More recently, alternative models in which leptin resistance is apparently 
physiologically adaptive have gained increasing attention. Using a model of an adaptive 
response and its return to a "normal" state helps us understand how a normally adaptive 
state can become maladaptive. Furthermore the mechanisms that control its return to a 
"normal" state can be used for therapeutic purposes in diet induced leptin resistance. 
Mammalian preparation for hibernation is one such example. Little brown bats increase 
their food intake prior to winter and exhibit a reduction in their sensitivity to leptin during 
this time (Kronfeld-Schor, Richardson, Silvia, Kunz, & Widmaier, 2000). Another 
example of adaptive leptin resistance is apparent in Siberian hamsters. Studies with this 
species have revealed that their sensitivity to leptin is dependent on the season. For 
example those hamsters that where exposed to photoperiods that mimicked shorter days 
for eight weeks and received two weeks of chronic leptin treatment depleted their fat 
stores. In contrast, there were no changes in food intake, body weight or fat stores in 
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those hamsters exposed to a long-day light cycle in addition to the leptin treatment (Atcha 
et al., 2000). 
It also appears that there are sex differences in leptin sensitivity. For example, icv 
administration of leptin to age and weight matched males and females led to a reduction 
in 24 hour food intake in the female rats only (Clegg, Riedy, Smith, Benoit, & Woods, 
2003). It has been proposed that one of the mechanisms regulating this difference may be 
estrogen since females have higher concentrations of this hormone. Clegg (2006) and her 
associates tested this hypothesis by comparing male and female animals that had their 
estrogen levels manipulated to varying degrees with castration, ovariectomy and 
subsequent administration of estradiol. The authors reported that intact females, castrated 
males and estradiol treated males all responded with reductions in food intake and body 
weight when treated centrally with leptin compared to those treated with a vehicle while 
intact males were not responsive to the same 3.5 microgram dose (Clegg, Brown, Woods, 
& Benoit, 2006). Thus these results suggest high estrogen levels increase sensitivity to 
leptin. 
Pregnancy has also been investigated as a model of leptin resistance. Increases in 
circulating leptin have been documented in both rodents and humans during gestation and 
reflect increased fat stores and/or production of this hormone by the placenta. In the rat, 
Chien et al. (1997) reported a 1.8 fold increase in serum leptin concentrations (Chien et 
al., 1997). Despite higher circulating levels of this satiating peptide, the consumption of 
food either remains the same or increases. For instance, Rocha and colleagues have 
reported that by the second and third weeks of gestation, rats consume 20% to 27% more 
food than non-pregnant animals (Rocha, Bing, Williams, & Puerta, 2003). Thus pregnant 
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rats and humans show an increased food intake in the presence of high circulating levels 
of leptin. Increase in NPY mRNA expression in the ARC has also been reported during 
pregnancy (Garcia, Gualillo, Seoane, Dieguez, & Senaris, 2003) consistent with a 
reduction in leptin signaling. 
Insensitivity to the effects of exogenous leptin on food intake in late pregnancy 
has been reported in ob/ob mice. Ob/ob mice are typically infertile, but fertility can be 
restored and pregnancy maintained with leptin treatment. In spite of daily leptin 
treatment, however, pregnant ob/ob mice increased their food intake from day 10 of 
pregnancy onward. From this it was concluded that a leptin resistance state in the ob/ob 
mice had emerged (Mounzih, Qiu, Ewart-Toland, & Chehab, 1998). 
Similar results have been reported in pregnant rats. A single icv injection of leptin 
decreased food intake and body weight in cycling and pregnant rats tested on day 7 post 
conception while being ineffective in changing the food intake of rats on Day 14 of 
pregnancy. This lack of a behavioral response to leptin was associated with a reduction in 
the phosphorylation of PSTAT3 in the VMH of the D14 pregnant group (Ladyman & 
Grattan, 2005). Reductions in expression of the mRNA for the long form of the leptin 
receptor within the hypothalamus have also been reported in pregnant rats, however they 
do not appear to relate to the time course of the appearance of leptin resistance in 
pregnancy (Szczepankiewicz, Wojciechowicz, Kaczmarek, & Nowak, 2006). 
The period during pregnancy when leptin resistance is observed coincides with a 
major change in hormonal profile: a switch from the bi-daily surges of prolactin (PRL) 
typical of the first half of pregnancy to a chronic increase in circulating placental 
lactogens (Rosenblatt. Siegel, & Mayer, 1979). Since placental lactogens can cross the 
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blood brain barrier and bind to central prolactin receptors (PRLR), this results in chronic 
PRLR stimulation. In both birds (Koch, Wingfield, & Buntin, 2004) and rats (Noel & 
Woodside, 1993; Sauve & Woodside, 2000), PRL has been shown to act in the brain to 
stimulate food intake. Most recently Naef & Woodside (2007) found that virgin Wistar 
rats receiving chronic central infusions of PRL increased their food intake and moreover 
did not show a decrease in either food intake or body weight following central leptin 
administration. Leptin induction of STAT3 phosphorylation was reduced in both the 
VMH and PVN of PRL infused rats. Further evidence for a role for PRL in the induction 
of leptin resistance comes from a study by Augustine et al (2008). These authors 
pseudoimpregnanted rats by mating them with vasectomized rats and found that 
pseudopregnancy alone was not sufficient to induce leptin resistance. Combining 
pseudopregnancy with chronic PRL infusion did prevent central leptin administration 
from decreasing food intake and body weight, however. Together, these studies suggest 
that leptin sensitivity is reduced during mid-late pregnancy and that this state is produced 
through exposure to chronically high levels of PRL. 
In the current study leptin sensitivity in another reproductive state, lactation, was 
examined. Lactation, like the latter half of pregnancy, is associated with high circulating 
levels of PRL (Ota and Yokoyama, 1967) accompanied by a dramatic increase in food 
intake (Cole & Hart, 1938; Malabu, Kilpatrick, Ware, Vernon, & Williams 1994). Unlike 
pregnancy, however, fat stores and leptin levels actually decrease during lactation. 
Because energy stored as fat during pregnancy is utilized to meet the energetic 
demands of milk production (Naismith, Richardson, & Pritchard, 1982), as fat stores are 
decreased, circulating leptin levels also decrease (Woodside, Abizaid & Walker, 2000; 
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Woodside, 2007). Interestingly, however, there is a significant increase in food intake 
prior to a significant decrease in circulating leptin levels (Woodside et al, 2000). 
Some studies have suggested that there is a reduction in the behavioural response 
to leptin in lactating rats. Woodside, Abizaid, & Walker (2000) exposed lactating dams to 
continuous subcutaneous infusions of leptin or a vehicle via osmotic minipumps. They 
found that although leptin treatment decreased body weight, it had no effect on food 
intake from postpartum days 8 to 22 when compared to vehicle animals. In contrast, 
leptin icv infusions reduced feeding from postpartum days 8 to 10, however this effect 
was transient so that by day 11 postpartum it had disappeared (Woodside et al., 2000) 
Crowley et al. (2004) found similar results when investigating the effects of the 
administration of subcutaneous infusions of leptin via osmotic minipumps in lactating 
females on orexigenic neuropeptide expression. The investigators reported that although 
they were successful at restoring serum leptin concentrations in lactating rats to levels 
observed in non-lactating rats, resulting in a decrease in levels of NPY mRNA 
expression, there were only minimal, inconsistent effects on the consumption of food 
(Crowley, Ramoz, Torto, & Kalra 2004). 
Finally, Roy and colleagues carried out an in vitro study in which Western blot 
analyses for PSTAT3 were carried out on the ARC of virgin and lactating rats following 
incubation in the presence or absence of lug of leptin. Following this treatment, the 
authors found that leptin resulted in a significant induction of PSTAT3 in the ARC of 
virgin females, while there was a complete absence of this same protein in lactating 
females (Roy et al., 2007). 
17 
Given the evidence suggesting some decrease in responses to leptin in lactating 
rats, the current work was carried out to compare the ability of central leptin 
administration to activate the JAK7STAT pathway among female rats that were cycling, 
in early lactation (Day 4 postpartum) or late lactation (Day 16 postpartum). To relate 
responses to leptin with lactational hyperphagia, in Experiment 1 we compared food 
intake among groups of cycling rats, rats on Day 4 postpartum and rats on Day 16 
postpartum. It was predicted that lactating rats would consume significantly more food 
than cycling females. In experiment 2, the ability of central leptin administration to 
induce phosphorylation of STAT3 in the VMH, PVN and ARC was compared among 
cycling and lactating rats on Day 4 or Day 16 postpartum. It was hypothesized that 
lactating animals would show a reduction in PSTAT3 activated cells in the VMH, PVN, 
and the ARC in response to central administration of leptin when compared to cycling 
females. 
GENERAL METHODS 
Experiment 1: Effect of Reproductive State on Food Intake Subjects 
28 female virgin Wistar rats were obtained from Charles River Breeding farms, 
St. Constant, Quebec. Rats weighed between 220 - 240 g upon arrival and were housed 
in clear plastic cages (20 X 45 X 50 cm). All subjects had ad libitum access to powdered 
rat chow (Agway Ltd; Syracuse, NY) and water. They were maintained on a 12-hour 
light/dark cycle with lights on at 08:00 and off at 20:00 h, at a room temperature of 20 + 
2 °C throughout the experiment. 
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Procedure 
Animals were housed in groups (4-5). Rats assigned to the lactating groups were 
mated by introducing a stud male into the group cage. Approximately 18 days later, all 
subjects, including virgins, were separated into clear individual plastic cages (20 X 45 X 
50 cm). At this time, food intake was monitored daily for all subjects. Vaginal smears of 
virgins were taken daily beginning 4 days prior to the first possible day of parturition for 
the lactating group, and this continued until the day of sacrifice. The day of parturition 
was designated day 0 postpartum (PPO). All litters of the dams were culled to 8 pups. 
Experiment 2: Effect of Central Leptin Administration on PSTAT3-ir Induction during 
Different Reproductive States 
Subjects 
Twenty-three female virgin Wistar rats were obtained from Charles River 
Breeding farms, St. Constant, Quebec. Rats weighed between 220 - 240 g upon arrival 
and were individually housed in clear plastic cages (20 X 45 X 50 cm). All subjects had 
ad libitum access to food and water and were maintained on a 12-hour light/dark cycle 
with lights on at 08:00 and off at 20:00 h, at a room temperature of 20 + 2 °C throughout 
the experiment. 
Surgeries 
All subjects underwent surgery to implant a cannula into the lateral ventricle. On 
the day of surgery, subjects were anaesthetized using ketamine-xylazine (5.7 mg 
ketaminc and 0.86 mg xylazine/ 100 g body weight). The head was shaved covering an 
area slightly posterior to the eyes to the base of the skull. The subjects were then placed 
in a stereotaxic apparatus. A sagittal incision approximately 2.5 cm in length was made 
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to expose the skull, which was subsequently cleaned. 4 holes were drilled and 3 jeweler 
screws were placed into the skull. A 22 gauge cannula was implanted into the lateral 
ventricle at the following co-ordinates AP: - 0.2 mm; L: -1.6 mm; DV: -5.0 mm from the 
surface of the skull (Paxinos & Watson 1996), and then fixed to the skull using dental 
cement. Following a minimum of 3 days of recovery from surgery, subjects were injected 
with angiotensin (50 ng in 2 1^) and water intake was monitored. If the injection resulted 
in at least 1 minute of rapid drinking, it was considered as evidence for accurate 
placement of the cannula. 
Procedure 
Subjects were randomly assigned to either the cycling or the lactating group. 
Subjects in the cycling group were housed individually in clear plastic cages until the day 
of infusion. Those subjects assigned to the lactating group were mated by pairing the 
subject with a sexually experienced male rat. Vaginal cytology of this group was 
monitored daily until sperm were detected. At this time, subjects were separated from the 
males and housed individually in clear plastic cages (20 X 45 X 50 cm) until parturition. 
The day of parturition was designated day 0 postpartum (PP0). At this time the litters of 
the dams were culled to 8 pups. 
Effect of stage of lactation on leptin signaling 
The ability of leptin to induce PSTAT3 was compared amongst 6 groups of rats: 
cycling rats treated with either leptin (CYC/LEP, N=4) or saline (CYC/SAL, N=3); 
lactating rats on day 4 postpartum treated with either leptin (DAY4/LEP, N=5) or saline 
(DAY4/SAL, N=4) and lactating rats on Day 16 postpartum treated with either leptin 
(DAY16/LEP, N=4) or saline (DAY16/SAL, N=3). Leptin (Peprotech, NJ) was dissolved 
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in dH20 and buffered with a 1 M tris solution to a ph of 7.4 and administered at a dose of 
4 jig in a volume of 4 JAI. Rats in saline groups were injected with a similar volume of 
saline. 30 minutes following the infusion, subjects were given an overdose of 
approximately 0.7 ml of Euthanyl (sodium pentobarbital) and transcardially perfused 
with saline followed by 2% paraformaldehyde. After brains were extracted, they were 
post-fixed for approximately 18 hours at room temperature in 2% paraformaldehyde. 
Brains were then placed in a 30% sucrose solution until they sank or for a maximum of 
72 hours and then stored at -80 °C until sectioned on a cryostat. Three sets of 40 urn 
sections were obtained throughout the hypothalamus and stored in Watson's 
cryoprotectant until processed for imrnunohistochemistry. 
PSTA T3 imrnunohistochemistry 
Sections through the hypothalamus were washed (3X5 min in PBS), incubated in 
1% H202 and 1% NaOH in PBS for 20 min, and then 0.03% sodium dodecyl sulphate 
for 10 min. Following 3 X 5-min washes in PBS, sections were placed in blocking 
solution (4% NGS in 0.25% Triton X-100 and 0.02% sodium azide in PBS) and 
incubated at room temperature for 1 h. Overnight, sections were placed in primary 
antibody directed against PSTAT3 (1:1000 dilution; Cell Signaling Technology, Inc. 
Beverly, MA) in blocking solution at 4 °C. The next day, sections were washed incubated 
in 3% NGS and secondary antibody (biotinylated goat-antirabbit; Vector) in blocking 
solution without sodium azide for 1 h, and washed once more. Sections were incubated in 
ABC reagent (Vector) for 2 h and developed with a DAB Vector kit. The mounting of 
sections onto gelatin slides was completed and these were then coverslipped using 
Permount (Fisher Scientific, Quebec, Canada), allowing for subsequent image analysis. 
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Image Analysis 
A Sony XC77 camera (Sony Corp., Kanagawaken, Japan) mounted upon a light 
microscope (Labolux Leitz GMBH, Wetzlar, Germany) was used to visualize the brain 
sections obtained in Experiment II. National Institutes of Health Image Analysis Software 
(1.60 b) (Bethesda, MD) installed on a Power Macintosh computer (G4; Apple 
Computer, Inc., Cupertino, CA) was used to capture images of the sections and these 
were saved as Tagged Image File Format picture files. 
For estimates of PSTAT3 expression in PVN, only sections in the medial area of 
the nucleus, (-1.80 mm from bregma) were used (Paxinos and Watson, 1986) and an 
average over all these sections was obtained. To obtain an estimate of PSTAT3 in the 
ARC and VMH, sections from -2.56 mm to -2.80 mm from bregma, were counted and 
the mean number of stained cells/section was calculated. To identify stained cells; 
sections from each experimental group across each assay that appeared to be stained were 
selected and a relative density greater than 150 was taken as proof of cell staining and 
recorded. An average of the density of the cells was then calculated to establish the 
criterion for each brain region across all experimental groups. The observer counting 
cells was blind to group membership. 
Statistical Analysis 
A univariate analysis of variance (ANOVA) was conducted on mean food intake 
(Experiment 1). A 3 (group: cycling, D4 lactation, D16 lactation) x 2 (treatment: saline or 
leptin) univariate analysis of variance (ANOVA) was carried out on PSTAT3 
immunoreactive (IR) cells (Experiment 2). Where appropriate, pair wise Fisher's least 




There was a significant main effect of group on food intake; F(2, 25) = 167.044, 
p<0.001. Fisher's LSD post hoc analysis revealed that on Day 4 of lactation, animals had 
significantly higher food intake than cycling rats (p<0.001), yet significantly less than 
Day 16 lactating females (pO.OOl; see Figure 1). 
Experiment 2 
As can be seen in Figure 2, leptin administration produced a robust increase in 
PSTAT3 -IR in the VMH that resulted in a significant main effect of treatment F(l,15) = 
20.982; p < 0.001). Neither the group effect nor the group x treatment interaction was 
significant. 
Figure 3 shows the number of PSTAT3-IR cells/section in the ARC. As in the 
VMH, leptin administration increased PSTAT3-IR in all groups resulting in a significant 
main effect for treatment F(l ,15) = 23.011, p< 0.001. There was no significant main 
effect of group, nor a significant interaction. 
As Figure 4 shows, although leptin administration also resulted in an increase in 
PSTAT3-1R in the PVN (significant main effect for treatment in the PVN; F(l,15) = 
76.069; p < 0.001), the strength of this effect was lower in both lactating groups resulting 
in significant effects for both group F(2,l 5) - 8.531; p < 0.003) and group x treatment 
interaction F(2, 15) = 5.425; p < 0.017). Pairwise posthoc comparisons using Fishers 
LSD revealed that the cycling group had a higher number of PSTAT3-IR cells than both 
Day 4 (p < 0.001) and Day 16 (p < 0.001) groups. Day 4 animals had higher PSTAT3 + 
cells compared to day 16 (p < 0.05) animals. 
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DISCUSSION 
The goal of the current work was to compare the ability of central leptin injections 
to induce PSTAT3-ir in hypothalamic nuclei of lactating and cycling rats. As expected, 
leptin injections induced a robust increase in PSTAT3-ir in the VMH, ARC and PVN in 
all groups. This response was attenuated in the PVN of lactating rats and the reduction in 
PSTAT3-ir was greater in the Day 16 than the Day 4 postpartum group. Together, these 
data suggest that lactation, like mid- to late pregnancy, is associated with a change in 
leptin sensitivity. Whether the reduction in leptin signaling through the JAK/STAT 
pathway in the PVN reflects a change in behavioral sensitivity to leptin remains to be 
determined but it has been suggested that the JAK/STAT pathway represents the major 
route through which leptin exerts its behavioural effects on food intake (Munzberg et al., 
2003). 
The decrease in leptin signaling that we observed is associated with increased 
food intake in lactating rats which, as the results of experiment 1 show, reaches 
approximately 200% of cycling levels by Day 4 postpartum and 325% of cycling levels 
by Day 16 postpartum. Leptin levels fall dramatically during lactation and reach a nadir 
at the time of peak milk production (Day 16 postpartum). Thus it is unlikely that leptin 
resistance is necessary to facilitate the extreme hyperphagia seen at the end of the second 
week of lactation. Rather, reductions in leptin sensitivity probably make their greatest 
contribution to lactational hyperphagia in the first week postpartum when fat stores and 
circulating leptin levels are similar to those of virgin rats. 
Although a decrease in leptin sensitivity appears to be common to both pregnancy 
and lactation there are some differences in these phenomena. One distinguishing feature 
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between the decrease in leptin sensitivity observed in the current study and that reported 
by Ladyman & Grattan (2005) is that during pregnancy reductions were localized in the 
VMH, whereas no effects in this area were observed in the current study. Ladyman & 
Grattan (2005) did not examine the PVN, but in previous work by Naef and Woodside 
(2007), chronic PRL infusions were found to decrease leptin-induced PSTAT3-ir in both 
the VMH and PVN. None of these studies found effects in the ARC although it has been 
reported that in DIO there is a reduction in PSTAT3 signaling in the DMH, VMH and 
ARC. It is not clear what effects DIO has on signaling within the PVN since the authors 
did not examine this area (Levin, Dunn-Meynell, & Banks 2004). It would be useful to 
confirm the current results using Western blotting techniques. The immunohistochemical 
technique used here provides good spatial resolution, giving a measure of the number of 
cells showing detectable immunoreactivity for the protein in question. However, Western 
blotting would further bolster our findings since it provides an indication of the total 
amount of protein present in the cell and could detect more subtle differences between 
groups. 
The current study, like those of Ladyman & Grattan (2005) and Levin et al. 
(2004) focused on one index of leptin signaling: the phosphorylation of STAT3. This 
focus is an important one since PSTAT3-ir indicates signaling activation within the 
JAK/STAT pathway and has been most strongly implicated in the anorectic effects of 
leptin. This hormone, however, also acts through both the MAP kinase (Bjorbaek et al., 
2001) and P13 kinase pathways (Zhao, Huan, Gupta, Pal, & Sahu 2002). In order to paint 
a complete picture of changes in leptin sensitivity during lactation it will be necessary in 
future studies to investigate whether there are any changes in leptin signaling through 
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these pathways during lactation by comparing the ability of central leptin to induce 
phosphorylated AKt and phosphorylated ERK in lactating and cycling rats. 
The lack of any apparent effect of lactation on the ability of leptin to induce 
pSTAT3-ir in the ARC is consistent with earlier results of Crowley et al. (2004). These 
authors showed that leptin administration to lactating rats from Days 8 to 10 postpartum 
reduced NPY expression in the ARC, presumably reflecting a local effect of leptin, but 
had only a small effect on food intake. The fact that leptin can have expected effects in 
one hypothalamic area but not produce the expected effects on food intake is indicative of 
the complexity of signals and neural circuits that control ingestive behavior. Leptin 
receptors have been localized to a number of hypothalamic nuclei implicated in the 
control of food intake including the PVN, VMH and ARC as well as the LH (Rosenblum 
et al., 1996; Mercer et al., 1996) that are all interconnected (Gutwiller & Beglinger, 2005, 
chap. 1) suggesting that leptin can act at multiple sites to modulate energy balance. For 
example, previous work has suggested that lesions to the PVN, VMH and ARC all result 
in a reduction in leptin's ability to decrease food intake and body weight (Choi et al., 
1999). Moreover, although investigations of direct administration of leptin into the PVN 
on food intake have not been carried out, microinjections into the VMH (Jacob, et al 
1997) and the ARC (Satoh et al., 1997) independently serve to reduce food intake. 
Recently most attention has focused on the roles of the ARC and VMH in the 
control of energy balance. However, the role of the PVN in the control of food intake is 
well-established. The PVN serves as an integrative site for many of the pathways 
involved in regulating energy balance (Gutzwiller & Beglinger, 2005, chap. 1). It 
receives projections from NPY/AGRP and the POMC/CART neurons in the ARC as well 
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as terminals of axons projecting from the LH. This nucleus is particularly sensitive to the 
effects of a variety of neurotransmitters including NPY, galanin, alpha-MSH, serotonin, 
norepinephrine, and opioid peptides; all of which have been implicated in appetite and 
energy regulation (Sahu, 2004). Furthermore, as with lesions of the VMH, damage to the 
PVN by way of electrolytic lesions or knife cuts result in hyperphagia and subsequent 
obesity (Leibowitz, Hammer, & Chang 1981). The PVN also contains a number of 
neuropeptides including CRH, TRH and oxytocin that are implicated in the control of 
food intake and there is some evidence that CRH and oxytocin neurons contain leptin 
receptors (Hakensson et al., 1998; Nishiyama, Makino, Asaba, & Hashimoto, 1999). 
Whether some specific subset of these cell populations are primarily affected by the 
changes in leptin signaling observed in the current study will be examined in the future 
using double immunohistochemistry. 
Although the current data show a clear reduction of leptin sensitivity in lactating 
rats, they do not shed light on the mechanisms through which such changes in sensitivity 
are produced. Perhaps the simplest explanation for these effects would be a down 
regulation in leptin receptor density in lactating rats (Scarpace, Matheny, Moore, & 
Turner, 2000). Another possibility is that the energetic demands of milk production and 
delivery give rise to signals that themselves modulate the response of leptin. A final 
alternative is that the hormonal state of the lactating rat modulates leptin responsivity. 
The finding that leptin sensitivity is reduced in early lactation prior to an appreciable loss 
of body fat or decrease in circulating leptin levels and when the loss of energy to the 
milk, although appreciable, is not at its peak, suggests that a simple increase in energy 
demand although possible, is not a likely explanation for changes in leptin sensitivity 
(Woodside et al., 2000). There is, however, considerable evidence to suggest that the 
hormonal state of lactating rats and, in particular, the high plasma levels of PRL and low 
levels of estrogen typical of lactation may play an important role in these effects 
(Woodside, 2007; Smith & Grove, 2002). 
PRL, which is a peptide hormone released from the pituitary in response to 
suckling stimulation, enters the brain via an active transport mechanism and has been 
shown to act centrally to increase food intake (Noel & Woodside, 1993; Sauve & 
Woodside, 1996; Naef & Woodside, 2007). Moreover, Naef and Woodside (2007) 
showed that chronic intracerebroventricular PRL infusions in virgin rats both increased 
food intake, suppressed the behavioral response to a central injection of leptin, and 
attenuated leptin-induced increases in PSTAT3-ir and Fos in both the VMH and PVN. In 
addition, Augustine et al. (2008) showed that the leptin resistance of mid-late gestation 
was likely to result from the high circulating levels of placental lactogen that activate 
PRLR in the brain. Given the results of the current study, it is interesting that Woodside 
and Sauve (1996) found that the PVN was a particularly important site for PRL in the 
control of food intake after central infusions of PRL resulted in an increase in feeding in 
virgin cycling rats. 
The way in which PRL might modulate leptin sensitivity is not clear. PRL 
receptors, like leptin receptors belong to the cytokine family (Roy et al. 2007) and PRL, 
like leptin, activates the JAK/STAT signaling pathway. However PRL induced activation 
of this pathway results in the phosphorylation of a number of STAT molecules including 
STAT3 as well as STAT5, which is considered to be the most functionally important for 
PRL's actions in the brain (Grattan & Kokay, 2008). Similar to leptin activation of the 
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JAK/STAT pathway, PRL induced activation of its receptor leads to the production of a 
number of signals of cytokine suppression (SOCS) proteins including SOCS3 (Anderson 
et al., 2006). It has been suggested by Bjorbaek (1999) that an up regulation in SOCS3 
could be the factor causing leptin resistance since it results in an inhibition of leptin 
signaling. However, in order for an intracellular SOCS3 increase to have an effect on 
leptin PSTAT3 cell activation, both leptin and PRL receptors must be colocalized on the 
same neuron. Recently, evidence of the coexpression of ObRb and PRLR was found to 
occur in the same neurons in the PVN (Roy et al., 2007) suggesting that at least in some 
brain areas the condition exists for this kind of interaction between PRL and leptin. 
Estrogen levels, which are low during lactation, generally act as an anorectic 
agent (Ladyman, 2008). Administration of this hormone results in reductions in food 
intake and fat stores, while opposite effects are observed with the removal of the ovaries 
(Morin & Fleming, 1978). One way in which estrogen exerts its effects on food intake is 
by potentiating the satiating effects of peptides such as CCK and leptin (Asarian & 
Geary, 2006). For example, Clegg et al (2006) have shown that female rats are more 
sensitive to effects of leptin on food intake than male rats and that this increased 
sensitivity depends on circulating estradiol levels. The recent demonstration (Gao et al., 
2007) that estrogen administration results in a reorganization of synaptic inputs to POMC 
neurons in the ARC are similar to that seen following leptin administration and represents 
another pathway through which estrogen may modulate energy balance. Interestingly, 
recent evidence suggests that in addition to genomic effects, estrogen administration can 
also lead to the phosphorylation of STAT proteins including STAT3 (Gao et al., 2007). 
Given the data suggesting estrogen potentiates leptin's actions, the absence of estrogen 
29 
during lactation might be expected to reduce leptin sensitivity. Evidence for the 
possibility of cross talk between both leptin and estrogen receptors has also emerged 
since the finding of colocalization of both sets of receptors in the neuronal perikarya in a 
number of hypothalamic nuclei including that of the parvicellular PVN (Diano, Kalra, 
Sakamoto, & Horvath, 1998). 
In conclusion, our finding of a reduction in leptin sensitivity during lactation 
provides some insight into the possible mechanisms underlying the ability of mothers to 
meet the high energetic demands that are typically associated with lactation. The results 
offer support to the idea that this adaptive form of reduction in leptin sensitivity is related 
to a disruption of the intracellular signaling of the JAK/STAT pathway specifically 
within the PVN, while not affecting the ARC or the VMH as observed in other models of 
resistance. Although distinct from DIO models, this adaptive model of reduced leptin 
sensitivity can be useful in providing further understanding into the signaling pathways of 
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less food than Day 4 lactating subjects. Furthermore Day 16 animals ate 
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Figure 2. Mean (+/-SEM) number of PSTAT3 + cells in the VMH. Rats that 
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Figure 3. Mean (+/-SEM) number of PSTAT3 + cells in the ARC. Animals that 










































Figure 4. Mean (+/-SEM) number of PSTAT3 + cells in the PVN. Rats that 
received leptin have an increased number of PSTAT3 + cells p<0.05 
level. Among leptin treated groups, cycling rats had a higher number 
of PSTAT3 + cells than both Day 4 and Day 16 rats and Day 4 animals 
had higher PSTAT3 + cells than Day 16 animals p<0.05 level. Groups 
having different letters are significantly different at the p<0.05 level. 
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